AstraZeneca PLC (AZN) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
AstraZeneca PLC, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Current interest-bearing loans and borrowings | |
|
|
|
|
|
Trade payables | |
|
|
|
|
|
Value added and payroll taxes and social security | |
|
|
|
|
|
Rebates and chargebacks | |
|
|
|
|
|
Other payables | |
|
|
|
|
|
Accruals | |
|
|
|
|
|
Trade and other payables | % |
% |
% |
% |
% |
|
Derivative financial instruments | |
|
|
|
|
|
Provisions | |
|
|
|
|
|
Income tax payable | |
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
|
Non-current interest-bearing loans and borrowings | |
|
|
|
|
|
Derivative financial instruments | |
|
|
|
|
|
Deferred tax liabilities | |
|
|
|
|
|
Retirement benefit obligations | |
|
|
|
|
|
Provisions | |
|
|
|
|
|
Other payables | |
|
|
|
|
|
Non-current liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Issued Ordinary Shares, $0.25 each | |
|
|
|
|
|
Redeemable Preference Shares, £1 each | |
|
|
|
|
|
Share capital | % |
% |
% |
% |
% |
|
Share premium account | |
|
|
|
|
|
Capital redemption reserve | |
|
|
|
|
|
Merger reserve | |
|
|
|
|
|
Other reserves | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Capital and reserves attributable to equity holders of the Company | % |
% |
% |
% |
% |
|
Non-controlling interests | |
|
|
|
|
|
Total equity | % |
% |
% |
% |
% |
|
Total liabilities and equity | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center